Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-27 Sale |
2023-02-28 6:28 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,156 | $1.6812 | $3,625 | 85,233 (Direct) |
View |
| 2022-11-28 Sale |
2022-11-29 5:25 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,116 | $2.7193 | $5,754 | 87,389 (Direct) |
View |
| 2022-08-26 Sale |
2022-08-29 9:18 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,190 | $4.0118 | $8,786 | 89,505 (Direct) |
View |
| 2022-05-26 Sale |
2022-05-27 5:32 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,154 | $1.9011 | $4,095 | 91,695 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-01 9:12 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,395 | $2.7795 | $6,657 | 93,849 (Direct) |
View |
| 2021-11-26 Sale |
2021-11-29 7:50 pm |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,541 | $4.8112 | $21,847 | 96,244 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-17 Option Award |
2025-03-19 8:56 pm |
N/A 2034-03-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer |
9,375 | $0 | 9,375 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 6:47 pm |
N/A 2035-01-29 |
RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer |
34,505 | $0 | 34,505 (Direct) |
View |
| 2024-03-27 Option Award |
2024-03-29 4:09 pm |
N/A 2034-03-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer |
187,500 | $0 | 187,500 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-17 5:03 pm |
N/A 2033-03-16 |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-25 Exercise |
2023-02-28 6:28 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 85,233 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 5:25 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 87,389 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-29 9:18 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 89,505 (Direct) |
View |
| 2022-05-25 Exercise |
2022-05-27 5:32 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 91,695 (Direct) |
View |
| 2022-03-17 Option Award |
2022-03-18 5:34 pm |
N/A 2032-03-17 |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-02-25 Exercise |
2022-03-01 9:12 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
4,127 | $0 | 93,849 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-29 7:50 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
8,254 | $0 | 96,244 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 5:46 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
32,689 | $1.26 | 163,775 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 5:46 pm |
N/A 2030-07-08 |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
34,750 | $0 | 163,775 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 5:46 pm |
N/A N/A |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
2,061 | $3.58 | 163,775 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 8:28 pm |
N/A 2031-03-26 |
Viracta Therapeutics Inc. | VIRX | Rojkjaer Lisa Chief Medical Officer |
126,890 | $0 | 126,890 (Direct) |
View |
Ownership |
2021-02-24 7:40 pm |
N/A N/A |
SUNESIS PHARMACEUTICALS INC | VIRX | Rojkjaer Lisa Chief Medical Officer |
0 | $0 | 295,187 (Direct) |
View |